435
Participants
Start Date
September 30, 2012
Primary Completion Date
May 31, 2014
Study Completion Date
March 31, 2015
HX575 epoetin alfa
Solution for subcutaneous injection. The drug is administered subcutaneously at least once per week over 52 weeks. The dose will be individually titrated to maintain hemoglobin levels between 10 to 11 g/dL.
US-licensed epoetin alfa
Solution for subcutaneous injection.
New York Hospital Queens, Fresh Meadows
Northeast Clinical Research Centers, Inc., Bethlehem
Delaware Valley Nephrology and Hypertension Associates, PC, Philadelphia
Germantown Dialysis, Germantown
Mendez Center For Clinical Research, LLC, Alexandria
West Virginia University Hospitals and Clinic, Morgantown
Boice-Willis Clinic, PA, Rocky Mount
Metrolina Nephrology Associates, PA, Charlotte
Southeastern Dialysis Center, Wilmington
Palmetto Nephrology PA, Orangeburg
SC Nephrology & Hypertension Center, Inc., Orangeburg
Atekha Nephrology Clinic LLC, Statesboro
Pines Clinical Research Inc., Hollywood
South Florida Nephrology, Coral Springs
Genesis Clinical Research Corporation, Tampa
Knoxville Kidney Center PLLC, Knoxville
Four Rivers Clinical Research, Incorporated, Paducah
Fresenius Management Services, Inc., Farmington
Creighton University, Omaha
Northwest Louisana Nephrology, Shreveport
Nephrology, P.A., Houston
Clinical Trial Network, Houston
Gamma Clinical Research Institute, Edinburg
Research Management, Inc., Austin
Southern Utah Kidney and Hypertension Center, St. George
Southwestern Kidney Institute, Tempe
Renal Medicine Associates, Albuquerque
Kidney Specialists of Southern Nevada, Las Vegas
Academic Medical Research Institute, Los Angeles
Ronald Reagan Medical Center, Department of Pharmaceutical Services, Drug Information Center, Los Angeles
Tower Nephrology Medical Group, Los Angeles
St Vincent Dialysis Center, Los Angeles
Kidney Research Center, Lynwood
Angel Kidney Care of Inglewood Dialysis Center, Inglewood
American Institute of Research, Whittier
Valley Renal Medical Group, Northridge
Renal Consultants Medical Group, Granada Hills
North America Research Institute, Azusa
Ontario Dialysis, Inc., Ontario
North America Research Institute, San Dimas
California Institute of Renal Research, Chula Vista
California Institute of Renal Research, La Mesa
California Institute of Renal Research, San Diego
La Jolla Clinical Research, Inc., San Diego
Apex Research of Riverside, Riverside
Alliance Research Centers, Laguna Hills
Pegasus Dialysis, LLC, Bakersfield
Central Nephrology Medical Group, Bakersfield
Capital Nephrology Medical Group, Sacramento
Seacoast Kidney and Hypertension Specialist, PLLC, Portsmouth
Rhode Island Hospital, Providence
Renal Associates, PA, San Antonio
Lead Sponsor
Sandoz
INDUSTRY